Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

New research by the Edwards group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.

Pre clinical study able to regrow bone in myeloma model

The research, led by Dr Sarah Gooding, is an equal collaboration between the groups of Prof Hal Drakesmith at the MRC Human Immunology Unit (RDM) and the group of Prof Claire Edwards at NDORMS and the Nuffield Department of Surgical Sciences.

Read more (MRC Weatherall Institute of Molecular Medicine webiste)